Jin, J., Hou, S., Yao, Y., Liu, M., Mao, L., Yang, M., . . . Wang, H. (2024). Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia. Advanced Science, 11(11), 1. https://doi.org/10.1002/advs.202305885
Chicago Style (17th ed.) CitationJin, Jie, et al. "Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia." Advanced Science 11, no. 11 (2024): 1. https://doi.org/10.1002/advs.202305885.
MLA (9th ed.) CitationJin, Jie, et al. "Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia." Advanced Science, vol. 11, no. 11, 2024, p. 1, https://doi.org/10.1002/advs.202305885.